EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
What Changes at Scale, and How Do You Know?
A pharmaceutical process that performs reliably on a few grams of material can behave very differently at pilot or commercial scale The temperature setpoint that worked on the bench the mixing time that delivered a uniform blend the feed rate that kept a reaction on track none of these is guaranteed to mean the same thing in larger equipment When that difference goes...
Advisory Board
KNOWLEDGE BANK
-
Articles
Ritonavir: How the Discovery of a New Polymorph Changed Drug Development Forever
AIDS is a chronic illness that gained global attention in the s It weakens the immune system of the body making it hard to fight infections When HIV enters the body it targets CD Tcells a type of white blood cell that helps defend against diseases It uses the machinery of Tcells to make new copies of the virus due to which the immune cells are destroyed As the virus spreads and the number of healt...
Strategic Partnerships and Collaborations in the European Pharmaceutical Industry
Pharma strategic partnerships are formal agreements in which two or more companies share resources risk and rewards to develop or commercialize medicines In Europe the main models are licensing codevelopment cocommercialization joint ventures and publicprivate consortia Companies choose based on how much risk they want to share how much control they need to keep
The Impact of Inflation and New Policies on Drug Pricing
Drug pricing has long been a contentious issue balancing the cost of innovation and the need for accessible healthcare In recent years the landscape has grown more complex due to rising inflation
The Competitive Generic Therapy (CGT)
Generic medications are critical in the healthcare sector due to their affordability and accessibility to the public while maintaining comparable quality efficacy and safety to that of branded products Generic medications research and development followed by commercialisation also fosters competition and innovation within the pharmaceutical
Why is Pharmacogenetics and Pharmacogenomics Important?
In a world of increasingly personalized medicine the fields of pharmacogenetics and pharmacogenomics are gaining importance These disciplines explore the relationship between an individuals genetic makeup
Exploring the Versatility of Using 3D Spheroid Models in Research
Cell culture technology forms the foundation of modern biological and pharmaceutical research For many years twodimensional culture systems have served as standard experimental models for studying cellular behavior disease mechanisms and therapeutic responses Although these models contribute significantly to scientific discovery they cannot fully replicate the structural and functional complexity...
-
Techno Trends
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue
-
Projects
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
-
Research Insights
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Strategic Partnerships and Collaborations in the European Pharmaceutical Industry
Sarah Richards
European pharmaceutical companies increasingly rely on strategic partnerships to share risk, cut costs, and reach fragmented markets. This article explains licensing, co-development, joint ventures, a...
-
2
The Impact of Inflation and New Policies on Drug Pricing
Kate Williamson
This article explores the intricate relationship between inflation, new policies, and drug pricing in the pharmaceutical industry. It delves into the mechanisms of inflation affecting raw materials, l...
-
3
The Competitive Generic Therapy (CGT)
Raghunandhan Painoori
Dr. Naveen Chella
The Competitive Generic Therapy (CGT) Act, introduced by the US FDA in 2017 under the Generic Drug User Fee Act (GDUFA), aims to lower drug costs by promoting generics where competition is limited. It...
-
4
Why is Pharmacogenetics and Pharmacogenomics Important?
Kate Williamson
Pharmacogenetics and pharmacogenomics, exploring genetic influences on drug response, are pivotal in personalized medicine. By tailoring treatments to individual genetic makeup, these fields enhance d...
-
5
Exploring the Versatility of Using 3D Spheroid Models in Research
Venkata Reddy Pothireddy
Three-dimensional (3D) spheroid models provide physiologically relevant alternatives to conventional two-dimensional (2D) cell cultures by better reproducing cell-to-cell and cell-to-matrix interactio...
press releases Read more...
Sino Biological Introduces AI-Trusted and Qualified Target Protein Collections for AI-Driven Discovery
As AI accelerates recombinant protein and antibody discovery for therapeutic and diagnostic development access to wellcharacterized target proteins is essential for evaluating AIdesigned molecules Sino Biological Inc Shenzhen Stock Exchange SZ a global biotechnology company
Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages
Sanofi announced today that the European Commission has approved VaxRabeo rabies virus inactivated strain Wistar for preexposure prophylaxis PrEP and postexposure prophylaxis PEP against rabies for all age groups
Datapharm appoints healthcare leaders to help shape the future of trusted medicines information
Datapharm the company behind emc the UKs trusted source of regulatorapproved medicines information today announced the formation of its Strategic Advisory Board bringing together senior figures from across pharma medical affairs and patient advocacy
London Biotechnology Show 2026 Concludes Two-Day Event, Bringing Global Life Sciences Community Together
The third edition of the London Biotechnology Show has concluded at ExCeL London following two days of discussions technology showcases and industry engagement that brought together stakeholders from across the global biotechnology and life sciences ecosystem
Events Read more...
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
24 - 25
Nov 2026BioPharma Deals Conference 2026
Science Congress Center, Munic...
25 - 25
Nov 2026What’s Next for Pharma Marketing in 2027
Landesmuseum Zürich, Zurich, S...
26 - 28
Nov 2026One Health Conference 2026
Thapar Institute of Engineerin...
01 - 03
Dec 2026Pharmaceutical Launch Excellence Summit
Novotel Amsterdam City, Nether...
01 - 03
Dec 202610th Antifibrotic Drug Development
Boston, MA at the Hotel Common...
02 - 04
Dec 2026Genome Informatics 2026
Wellcome Genome Campus, UK
03 - 04
Dec 2026Pharmacy and Pharmaceutical Conference
Madrid, Spain
LATEST NEWS Read more...
DISCO Pharmaceuticals Partners with AbbVie to Develop Next-Generation Bispecific Therapies for Solid Tumours
DISCO Pharmaceuticals has entered into a strategic collaboration and optiontolicense agreement with AbbVie to discover and develop nextgeneration ANDgated bispecific therapies for solid tumours with significant unmet medical needs
CAI Enters Agreement with PQE Group to Expand Global Life Sciences Services
CAI a professional services firm specialising in operational readiness and excellence for life sciences and other critical industries has entered into a definitive agreement with PQE Group a global consulting firm focused on quality compliance
Erasca Partners with Bristol Myers Squibb to Study ERAS-0015 Combination Therapy for Pancreatic Cancer
Erasca Inc a clinicalstage precision oncology company focused on developing treatments for cancers driven by the RASMAPK signalling pathway has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb BMS
Libtayo Receives EU Approval for Extended Dosing and Shorter Infusion Times Across Six Cancer Indications
Regeneron Pharmaceuticals has received European Commission EC approval for an alternative dosing schedule for Libtayo cemiplimab across all six of its approved indications for skin lung and cervical cancers in the European Union EU
FDA approves Roche’s Wilserdly for ER-positive, ESR1-mutated advanced breast cancer
Roche has received approval from the US Food and Drug Administration FDA for Wilserdly giredestrant in combination with everolimus to treat adults with oestrogen receptor ERpositive human epidermal growth factor receptor HERnegative ESRmutated locally advanced or metastatic breast cancer
European Commission approves Revolution Medicines’ RASONQUE for metastatic pancreatic cancer
Revolution Medicines has received European Commission EC approval for RASONQUE daraxonrasib to treat adults with metastatic pancreatic adenocarcinoma who have received at least one previous systemic therapy The medicine is taken once daily as an oral tablet and is approved for patients with or witho...









